Our approach

We partner entrepreneurs and companies to scale and grow internationally

What We Invest In

Biotechnology and medical technology are our core focus. We seek first in class or differentiated best in class therapies and platforms that transform patients’ treatment paradigm. We invest in medical technologies that improve how and where patients’ care pathways are delivered.

We lead seed and Series A rounds and are equally comfortable to partner exceptional founders for company formation.

Bridging Global Networks

We partner and support our companies as they scale and grow. Our team brings deep networks and expertise from Asia, Europe and US, complemented by our anchor shareholder, Temasek.

Asia’s life sciences ecosystem is growing with strong momentum, providing rich sources of innovation, talent and capabilities critical for life sciences ventures to succeed.

In Singapore, we have established extensive and trusted relationships across its vibrant ecosystem – universities, research institutions, hospitals and government agencies.

We have proprietary networks in China, including working closely with Temasek-affiliated True Light Capital and Biosparc (Suzhou), to access the thriving China life sciences ecosystem.

We also co-invest with top tier VC funds and strategic investors from Asia, Europe & US to broaden our international access.